Your browser doesn't support javascript.
loading
Traditional Chinese Medicine Regulates Signaling Pathways to Treat Vitiligo:A Review / 中国实验方剂学杂志
Chinese Journal of Experimental Traditional Medical Formulae ; (24): 233-240, 2023.
Artigo em Chinês | WPRIM | ID: wpr-998184
ABSTRACT
Vitiligo, a skin pigmentation disorder caused by the loss of melanocytes in the basal layer of the skin, is manifested as creamy white or ivory white pigmented islands on the headfacehairareolagenitalsmucous membranes and traumatic areas with distinct borders, seriously affecting the patient’s social, physical, and mental health. The disease has attracted wide attention in the medical circle as a difficult aesthetic dermatosis with an increasing prevalence year by year. There are still blind spots in the hypotheses that autoimmunitymelanocyte autophagyoxidative stress, autocytotoxicity, neurohumors, and genetic and environmental factors are associated with the pathogenesis of this disease. The commonly used Western medical therapies, including glucocorticoids, small-molecule antagonists, calcium-regulated neurophosphatase inhibitors, biologicsvitamin D derivatives, phototherapy, and surgery are flawed with side effects and prone to recurrence. Traditional Chinese Medicine (TCM) can treat vitiligo via a wide range of pathways and targets, with definite effects and low adverse reactions. Studies have demonstrated that TCM can promote autophagy of melanocytes and protect them from oxidative stress. However, there are few systematic summaries of the signaling pathways in the TCM treatment of vitiligo. Therefore, this paper introduces the main signaling pathways involved in the TCM treatment of vitiligo by reviewing the relevant articles published at home and abroad in recent years. Specifically, the signaling pathways include the molecular hydrogen-activated nuclear factor erythroid-related factor 2 (Nrf2), tyrosine kinase receptor (c-Kit), nuclear transcription factor-κB (NF-κB), Janus tyrosine protein kinase (JAK), mitogen-activated protein kinase (MAPK), phosphatidylinositol 3-kinase (PI3K)/protein kinase B (Akt), and adenosine monophosphate-activated protein kinase (AMPK) signaling pathways.

Texto completo: DisponíveL Índice: WPRIM (Pacífico Ocidental) Idioma: Chinês Revista: Chinese Journal of Experimental Traditional Medical Formulae Ano de publicação: 2023 Tipo de documento: Artigo

Similares

MEDLINE

...
LILACS

LIS

Texto completo: DisponíveL Índice: WPRIM (Pacífico Ocidental) Idioma: Chinês Revista: Chinese Journal of Experimental Traditional Medical Formulae Ano de publicação: 2023 Tipo de documento: Artigo